会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • CANCER-TESTIS ANTIGENS
    • 癌症检测抗体
    • WO2002078526A2
    • 2002-10-10
    • PCT/US2002/009808
    • 2002-03-29
    • LUDWIG INSTITUTE FOR CANCER RESEARCHCORNELL RESEARCH FOUNDATION, INCOLD, Lloyd, J.SCANLAN, Matthew, J.CHEN, Yao-Tseng
    • OLD, Lloyd, J.SCANLAN, Matthew, J.CHEN, Yao-Tseng
    • A61B
    • C07K14/4748A61K39/00A61K2039/505A61K2039/5156A61K2039/53C07K16/30C12Q1/6883C12Q1/6886C12Q2600/158C12Q2600/16G01N33/57407
    • Cancer-testis (CT) antigens have been identified by screening public databases for transcripts that are expressed in tumor tissues and a limited set of normal tissues, or by screening for genes that are expressed in cancer and testis tissues (but not other normal tissues). The invention relates to nucleic acids and encoded polypeptides which are CT antigens expressed in patients afflicted with cancer. The invention provides, inter alia isolated nucleic acid molecules, expression vectors containing those molecules and host cells transfected with those molecules. The invention also provides isolated proteins and peptides, antibodies to those proteins and peptides and cytotoxic T lymphocytes which recognize the proteins and peptides. Fragments of the foregoing including functional fragments and variants also are provided. Kits containing the foregoing molecules additionally are provided. The molecules provided by the invention can be used in the diagnosis, monitoring, research, or treatment of conditions characterized by the expression of one or more CT antigens.
    • 已经通过筛选在肿瘤组织和有限的正常组织中表达的转录本的公共数据库,或通过筛选在癌和睾丸组织(但不是其他正常组织)中表达的基因来鉴定癌 - 睾丸(CT)抗原。 。 本发明涉及在患有癌症的患者中表达的CT抗原的核酸和编码多肽。 本发明提供了分离的核酸分子,含有这些分子的表达载体和用这些分子转染的宿主细胞。 本发明还提供分离的蛋白质和肽,这些蛋白质和肽的抗体以及识别蛋白质和肽的细胞毒性T淋巴细胞。 还提供了前述的片段,包括功能片段和变体。 另外提供了含有上述分子的试剂盒。 本发明提供的分子可用于诊断,监测,研究或治疗以一种或多种CT抗原表达为特征的病症。